Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5604]
News [13558]
Articles [218]
Editorials [5]
Conferences [266]
elearning [17]

Diet and exercise interventions for cancer survivors

Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alabama, USA
Diet and exercise interventions for cancer survivors ( Prof Wendy Demark-Wahnefried – UAB Comprehensive Cancer Center, Birmingham, Alabama, USA )
14 Nov 2012

Patient involvement in improvements in standard of care

Tom Haswell - VNCRI and NCRN Consumer Liaison Groups
Patient involvement in improvements in standard of care ( Tom Haswell - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012

Benefits of participating in clinical trials and patient liaison groups

Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups
Benefits of participating in clinical trials and patient liaison groups ( Shirley Harrison - VNCRI and NCRN Consumer Liaison Groups )
14 Nov 2012

Treatment of antiphospholipid syndrome with aspirin

Prof Graham Hughes – St Thomas Hospital, London, UK
Treatment of antiphospholipid syndrome with aspirin ( Prof Graham Hughes – St Thomas Hospital, London, UK )
1 Nov 2012

The ASPree study: ASPirin in Reducing Events in the Elderly

Prof John McNeil – Monash University, Prahran, Australia
The ASPree study: ASPirin in Reducing Events in the Elderly ( Prof John McNeil – Monash University, Prahran, Australia )
1 Nov 2012

Effects of aspirin on the progression of cancer

Prof Peter Rothwell – Oxford University, UK
Effects of aspirin on the progression of cancer ( Prof Peter Rothwell – Oxford University, UK )
1 Nov 2012

Side effects of treating with aspirin

Prof Peter Elwood – Cardiff University, UK
Side effects of treating with aspirin ( Prof Peter Elwood – Cardiff University, UK )
1 Nov 2012

Aspirin in cardiovascular disease

Prof Carlo Patrono – Catholic University School of Medicine in Rome, Italy
Aspirin in cardiovascular disease ( Prof Carlo Patrono – Catholic University School of Medicine in Rome, Italy )
1 Nov 2012

Effectiveness of PARP inhibitors in ovarian cancer

Prof Jonathan Ledermann - University College London, UK
Effectiveness of PARP inhibitors in ovarian cancer ( Prof Jonathan Ledermann - University College London, UK )
1 Nov 2012

Retrospective study on adjuvant therapy in vulva cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Retrospective study on adjuvant therapy in vulva cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf, Hamburg, Germany )
31 Oct 2012

Phase III HECTOR study: recurring platinum sensitive ovarian cancer

Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany
Phase III HECTOR study: recurring platinum sensitive ovarian cancer ( Prof Sven Mahner - University Medical Center Hamburg-Eppendorf , Hamburg, Germany )
31 Oct 2012

AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer

Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway
AURELIA trial, palliative chemotherapy with bevacizumab in resistant, recurrent ovarian cancer ( Dr Gunnar Kristensen – Norwegian Radium Hospital, Oslo, Norway )
30 Oct 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation